Filter Search


Healthcare and Medical


Location Summary Deadline
Norway Prior Information Notice 2025-11-16
India Procurement Of Pac Items For Pathology Department At Dduh, Dimer Kits, Dimer Control, Factor Diluent. 2025-11-16
Germany Open House Medicinal Department Treaties Ticagrelor, Atc B01ac24 2025-11-16
Germany Open House Pharmaceutical Dact Treaties Iron (iii) Hydroxid Polymaltose Complex, Atc B03ac01 2025-11-16
Germany Completion Non -existing Discount Agreements According To § 130a Para. 8 Sgb V To The Active Ingredients Mentioned With A Final Option In The Context Of The So -called Open -house Process. 2025-11-16
Germany Completion Of A Non -exclusive Discount Agreement According To Section 130a (8) Sgb V On The Active Ingredient Denosumab, Atc M05bx04 For The Time 01.07.2025 - 30.06.2026 (plus Extension Option 1x 12 Months) 2025-11-16
Germany Completion Of A Non -exclusive Discount Agreement According To Section 130a (8) Sgb V On The Active Ingredient Dolutegravir + Rilpivirin, Atc J05ar21 For The Time 01.07.2025 - 30.06.2027 2025-11-16
Germany Completion Of A Non -exclusive Discount Agreement According To Section 130a (8) Sgb V On The Active Ingredient Fusidic Acid, Atc D06ax01 For The Period 01.07.2025 - 30.06.2027 (plus Extension Option 1x12 Months) 2025-11-16
Germany Completion Of A Non -exclusive Discount Agreement According To Section 130a (8) Sgb V On The Active Ingredient Lamivudin + Dolutegravir, Atc J05ar25 For The Period 01.07.2025 - 30.06.2027 2025-11-16
Germany Open House Original Discount Contracts 2025-20 - Metformin/dapagliflozin (combination Of Active Ingredients) 2025-11-16
Whats app